Greener and efficient processes: Quaternary Ammonium Salts
Quaternary Ammonium Salts play a crucial part in Organic Chemistry processes at many major industries. Discover why.
What are Quaternary Ammonium Salts (Quats)?
Dishman Carbogen Amcis Ltd. has rich expertise in Quaternary Ammonium Salts (Quats), and boasts an established, wide portfolio. But do you know exactly what Quats are, how and where they are used, and most importantly... why would you use them?
Quaternary Ammonium Salts (Quats) are a crucial part of organic chemistry processes across many major industries.
The quaternary ammonium cations are permanently charged, independent of the pH of their solution. Their permanent positive charge and hydrophilic carbon chains make Quats excellent Phase Transfer Catalysts. They are widely used in the productions of numerous products such as: Additives, Agrochemicals, Dyes, Pharmaceuticals, Paint & Coatings… and many more.
Due to their strong antimicrobial activity, they are also used in Disinfectants/Antiseptics. Other uses also include polymer modification, pollution treatment and the removal/destruction of impurities in wastes & product streams.
A wide range of reactions can make use of Quats as catalysts or reagents such as Etherification, Wittig reaction, Alkene synthesis, Borohydride Reduction and Chloromethylation… to name a few.
Diverse industries from Pharmaceuticals, Agrochemicals to Electronics are using Quats for the variety of their advantages.
Indeed, the use of Quats offers a number of benefits from an economic, environmental and quality-related point of view. These include:
- Easy and reliable up-scaling
- Low investments costs
- Elimination of expensive and dangerous reactants such as metal alkoxides
- Mild reaction conditions with increased process reliability
- Flexibility in solvent choice
- Minimization of industrial waste
- High yield and purity of the end
- Reduced reaction time
- Increased reaction rates that leads to enhanced selectivity
- Reduction of side products output
- Increased reactor volume efficiency
- Reduction or even elimination of the use of organic solvents
Therefore, Quats make many processes greener and more efficient by using less solvent, less energy & producing less harmful waste.
Contact Dishman Carbogen Amcis Ltd. to learn more about our established portfolio of Ammonium and Phosphonium Quats, and our extensive R&D capabilities.
Related News
-
News Women in Pharma: Moving beyond discussions and into best practice at CPHI Milan
In this second CPHI Milan special of our monthly series, we cover the key takeaways from the Diversity & Wellbeing track held on October 10, 2024. -
News AstraZeneca invests in AI collaboration for cancer drug trials
The British-Swedish pharmaceutical giant is partnering with biotechnology firm Immunai Inc to increase the efficiency of some cancer drug trials. -
News Ozempic and Wegovy prices questioned as Novo Nordisk faces US Senate hearing
The CEO of Novo Nordisk was grilled during a US Senate committee hearing on September 24, 2024, in which the exorbitant prices of the Danish company’s blockbuster drugs Ozempic and Wegovy were called into question. -
News The BIOSECURE Act: implications for the pharma supply chain
On September 9, 2024, the US House of Representatives voted to pass the bill titled the BIOSECURE Act (the Act), which lists several Chinese companies in the pharmaceutical supply chain. The Act will prohibit American companies from contracting or doin... -
News On Track at CPHI Milan: Thermo Fisher Scientific Track Sponsor interview
With CPHI Milan just around the corner, we sat down with some of the sponsors for this year’s conference tracks to discuss the most pressing topics in pharma. -
News CPHI Milan Speaker Spotlight: Pharma Manufacturing and Localisation in Africa
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conferences. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Eli Lilly licenses rheumatoid arthritis manufacturing in Africa
American pharmaceutical company Eli Lilly has signed a partnership with Egyptian organisation Eva Pharma to localise manufacturing of rheumatoid arthritis treatments in Africa.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance